Volume 17, Number 8—August 2011
Research
Seroprevalence of Trichodysplasia Spinulosa–associated Polyomavirus
Figure 2

Figure 2. Cross-reactivity between trichodysplasia spinulosa–polyomavirus (TSV), Merkel cell polyomavirus (MCV), and BKV polyomavirus viral protein 1 (VP1). Correlation between seroreactivity against TSV VP1 and MCV VP1 (A) and BKV VP1 (B) was analyzed by using Bio-Plex 100 analyzer (Bio-Rad Laboratories, Hercules, CA, USA) with 30 serum samples from renal transplant patients, the Netherlands. Each circle represents 1 serum sample, and the line represents results of linear regression analyses. Correlation coefficients (r2) were determined by using GraphPad Prism software (GraphPad Software Inc., La Jolla, CA, USA). MFI, median fluorescent intensity.
Page created: August 15, 2011
Page updated: August 15, 2011
Page reviewed: August 15, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.